Reports Q3 revenue $5.361M vs $213,000 last year. Mori Arkin, Executive Chairman of Sol-Gel, stated: “The quarterly results reflects our ...
Mori Arkin's appointment as interim CEO as of January 1, 2025 approved by shareholdersPhase 3 clinical trial of SGT-610 for Gorlin Syndrome is ...
Research on bioinspired hydrogels reveals their potential in artificial photosynthesis, addressing water-splitting challenges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback